Team & # 39; & # 39 researchers; the leading MS in the world, led by Dr. Oh JIWON, Selected to start work on – Internet
the first Canadian cohort to study the progression of & # 39; multiple sclerosis
TORONTO, 6 & # 39; December 2018 / CNW / – The Society of Canada Multiple Sclerosis and Brain Canada Foundation announced today the team chosen to lead the Canadian cohort to study the progression of multiple sclerosis (MS). Dr. Oh JIWON, Based on St. Michael The hospital, and her team & # 39; nearly 50 leading MS researcher at & # 39; various disciplines from across the country, chosen to run the Proactive Study & # 39; Cohort $ 7 + million Canadian for People Living with & # 39; MS (CanProCo). Partner & # 39; funding brain Canada receive financial support from Health Canada through the Brain Research Fund of Canada. Biogen Canada is also a founding partner and & # 39; project financing, providing support from the beginning.
Dr. Oh, the neurologist and researcher, conducting research on the development of & # 39; advanced techniques & # 39; magnetic resonance imaging (MRI) in MS. Does & # 39; MD from the University & # 39; Queen followed by a PhD and bag & # 39; clinical study at university Johns Hopkins School of Medicine, Dr. Oh is dedicated to leading the charge against the Member States through the efforts & # 39; its continuous ongoing research. She helped start the Imaging of & # 39; American & # 39; On the Cooperative & # 39; Multiple Sclerosis, which brings together academic centers that use MRI for research & # 39; Member States.
"We are thrilled to have Dr. Oh JIWON and the team & # 39; & # 39 conducts its research; forward this unique project, which focuses on answering & # 39; some puzzling questions about MS, "said Dr. Pamela Valentine, President and CEO, MS Society of Canada. "As a leader in the research of the Member States, Dr Oh dedicated her career to study this disease and find a cure. The team is collaborating on this project brings much wisdom in the table With their expertise and and support from Biogen brain Canada, This group has the potential to help the tens of & # 39; & # 39 thousands; Canadians living with & # 39; MS. "
"Canada has one of the highest rates of & # 39; MS in the world, so it is imperative that we learn more about this disease and how to move & # 39; forward," said Dr. Oh. "With the acquisition of & # 39; a better understanding of MS progression, we can make a significant impact on how people manage their disease and improve the quality of life for many Canadians."
The CanProCo is the first project of its kind in Canada in order to gain a better understanding of the unpredictable nature of the disease progression. In addition to understanding why some people walk & # 39; ahead in their disease and some people do not, researchers try to identify the trigger that lead to progression and establish ways to manage those triggers while measuring the MS impact on individuals as well as the Canadian health care system.
Besides Dr. Oh, the leading researchers on the team include: Dr. Shannon Kolind (University of British Columbia), Dr. Larry Lynd (University of British Columbia), Dr. Scott Patten (University & # 39; Calgary), Dr. Alexandre Prat (Center de Recherche du CHUM), Dr. Roger Tam (University of British Columbia), And Dr. Anthony Traboulsee (University of British Columbia).
The CanProCo will provide Dr. Oh and her team the opportunity to collect and analyze data from Canadians living with & # 39; Member States, covering biological factors, physical and economic, to better understand unique experiences & # 39; each individual with & # 39; Member States and gain knowledge about the progress. Using data collected from the cohort, the researchers hope to improve diagnosis, treatment and potentially prevent the manifestation of the disease. The results of & # 39; this study have the potential to impact on how people live with Member States and how to talk about MS progression b & # 39; in general.
The long-term monitoring of the progression of the Member States will help build a centralized and open source & # 39; data has the potential to help researchers not only MS but can & # 39; is also relevant for researchers studying other neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's and amyotrophic Lateral Skuterżi & # 39; s, because of the potential mechanisms for & # 39; common diseases.
Recruitment for people living with & # 39; MS to take part in & # 39; this study begin in early 2019. click here for more information about the Progression Cohort United States of Canada.
Background on the Study & # 39; Cohort Canadian Proactive for People Living with Member States (CanProCo)
Progression – or stable disease flare and increase in disability – is reality & # 39; challenge faced by people affected by the Member States, and despite great advances in Member States' research, the mechanism a & # 39; progression and the ways in which researchers can follow the clinical progression are not yet fully understood. The CanProCo can & # 39; have significant implications for how people living with MS manage and understand their illness from diagnosis and during the various stages of the disease. This study will look at the progress of biological perspectives, physical and economic, and implies b & # 39; meaningful ways people living with & # 39; MS to capture their individual experiences. In Ultimately, the goal of cohorts is to combine the biological findings to the real world and the clinical findings to create a comprehensive picture of the progression in MS, hoping that researchers better understand unpredictable-kind MS and find a cure.
This investment & # 39; $ 7 + million in Canadian research being generated by the founding partners. The MS Society is grateful to manage donors, the PCL Construction and Bennett Jones LLP for their generous support in $ 1.25 million and $ 1 million, Respectively, as well as many individuals who have made significant contributions.
About multiple sclerosis and Society & # 39; MS of Canada
Canada has one of the highest rates of & # 39; with multiple sclerosis in the world & # 39; 11 Canadians diagnosed with MS every day. MS is a chronic, often disabling central nervous system includes the brain, spinal cord and optic nerve. The majority of people with MS are diagnosed between the ages of & # 39; 15 and 40 and the unpredictable effects of the disease last for the rest of & # 39; lives. The MS Society provides programs and services for people with MS and their families, for those living with the Member States, and fund research to help improve the quality of life for people living with MS in ultimately find a cure for this disease. Please visit society & # 39; the imsieħba.ka or call 1-800-268-7582 to make a donation or for more information. Join the conversation and connect with MS online community. Find the MS Society on Twitter, Instagram or like our Facebook page.
about brain Canada and fund & # 39; Research of Brain Canada
brain Canada is a national registered charity headquartered Montreal, Which enables and supports excellent brain research, innovation and changing paradigms in 2008 Canada. Since 1998, brain Canada made the case for the brain as a complex system and b & # 39; common features in the range of & # 39; neurological disorders, mental illness and addictions, brain injuries and & # 39; the spinal cord. Looking at the brain as one system highlighted the need for greater collaboration between disciplines and institutions, and smarter way to invest in research of the brain that is focused on outcomes that benefit patients and families. Brain Canada & # 39; s vision is to understand the brain, in health and disease, to improve the lives and achieve impact on society.
The fund & # 39; Research of Brain & # 39; Canada is a public-private partnership between the Government of Canada and brain Canada, Designed to encourage Canadians to increase their support for research of the brain, and maximize the impact and efficiency of & # 39; those investments brain Canada undertook $ 115 million from private donors and non-federal partners, now totaling more than 100 – that Health Canada has borne $ 120 million. For more information, visit or follow us www.braincanada.ca Twitter or Facebook.
SOURCE The Multiple Sclerosis Society of Canada
For further information: Media contacts: Jennifer Asselin, MS Society of Canada, 1-800-268-7582 ext. 3144, [email protected]; Michael Oliveira, St. Michael's Hospital, 416-864-5047, [email protected]